1. Home
  2. MYNZ vs PET Comparison

MYNZ vs PET Comparison

Compare MYNZ & PET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYNZ
  • PET
  • Stock Information
  • Founded
  • MYNZ 2021
  • PET 2015
  • Country
  • MYNZ Germany
  • PET United States
  • Employees
  • MYNZ N/A
  • PET N/A
  • Industry
  • MYNZ Biotechnology: Pharmaceutical Preparations
  • PET EDP Services
  • Sector
  • MYNZ Health Care
  • PET Technology
  • Exchange
  • MYNZ Nasdaq
  • PET Nasdaq
  • Market Cap
  • MYNZ 5.5M
  • PET 5.9M
  • IPO Year
  • MYNZ 2021
  • PET N/A
  • Fundamental
  • Price
  • MYNZ $1.37
  • PET $0.11
  • Analyst Decision
  • MYNZ Buy
  • PET Strong Buy
  • Analyst Count
  • MYNZ 2
  • PET 3
  • Target Price
  • MYNZ $14.00
  • PET $4.17
  • AVG Volume (30 Days)
  • MYNZ 118.7K
  • PET 4.6M
  • Earning Date
  • MYNZ 07-07-2025
  • PET 08-06-2025
  • Dividend Yield
  • MYNZ N/A
  • PET N/A
  • EPS Growth
  • MYNZ N/A
  • PET N/A
  • EPS
  • MYNZ N/A
  • PET N/A
  • Revenue
  • MYNZ $893,991.00
  • PET $62,453,000.00
  • Revenue This Year
  • MYNZ $26.06
  • PET $7.87
  • Revenue Next Year
  • MYNZ $4.97
  • PET $122.23
  • P/E Ratio
  • MYNZ N/A
  • PET N/A
  • Revenue Growth
  • MYNZ N/A
  • PET N/A
  • 52 Week Low
  • MYNZ $1.34
  • PET $0.08
  • 52 Week High
  • MYNZ $22.40
  • PET $1.79
  • Technical
  • Relative Strength Index (RSI)
  • MYNZ 23.25
  • PET 42.91
  • Support Level
  • MYNZ $1.34
  • PET $0.09
  • Resistance Level
  • MYNZ $1.48
  • PET $0.13
  • Average True Range (ATR)
  • MYNZ 0.13
  • PET 0.01
  • MACD
  • MYNZ -0.01
  • PET -0.00
  • Stochastic Oscillator
  • MYNZ 3.72
  • PET 30.45

About MYNZ Mainz Biomed N.V.

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.

About PET Wag! Group Co.

Wag Group Co develops and supports a proprietary marketplace technology platform available as a website and mobile app that enables independent Pet Caregivers to connect with pet parents. The platform allows pet parents to make pet service requests in the platform, which can then be fulfilled by Pet Caregivers. Wag supports dog walking, pet sitting, pet boarding, drop-in visits at the pet parent's home, advice from licensed pet experts, training services, pet insurance comparison tools and pet wellness plans.

Share on Social Networks: